Results 201 to 210 of about 38,942 (318)

Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.

Journal of the American Medical Association (JAMA), 2015
J. Gross, A. Glassman, L. Jampol, S. Inusah, L. Aiello, A. Antoszyk, C. Baker, B. Berger, N. Bressler, D. Browning, M. Elman, F. Ferris, S. Friedman, D. Marcus, M. Melia, Cynthia R. Stockdale, Jennifer K. Sun, R. Beck   +17 more
semanticscholar   +1 more source

Retreatment and Reactivation Rates Following Bevacizumab, Ranibizumab, Aflibercept, and Laser for Retinopathy of Prematurity: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Alghamdi A, Alasmari F, Aletani T, Ezzi S, Alharbi S, Alasmari TF, Alalgum H, Bin Sawad M, Talaat K.   +8 more
europepmc   +1 more source

Photodynamic therapy combined with ranibizumab for polypoidal choroidal vasculopathy: results of a 1-year preliminary study [PDF]

, 2010
Paisan Ruamviboonsuk, Mongkol Tadarati, Sumeth Vanichvaranont, Prut Hanutsaha, Nattapol Pokawattana   +4 more
openalex   +1 more source

Novel anti-VEGF scFv antibodies with superior in vitro and in vivo activities. [PDF]

Sci Rep
Cakan-Akdogan G, Erez O, Ozer C, Onal E, Mert O, Gullu S, Arslan M, Avci ME, Inan M, Kalyoncu S.   +9 more
europepmc   +1 more source

Complete Resolution of a Giant Pigment Epithelial Detachment Secondary to Exudative Age-Related Macular Degeneration after a Single Intravitreal Ranibizumab (Lucentis) Injection: Results Documented by Optical Coherence Tomography [PDF]

, 2010
Eleni Loukianou, Nacima Kisma, Robin Hamilton   +2 more
openalex   +1 more source

Anti-VEGF treatment switch in real-world DME patients: ranibizumab versus aflibercept for bevacizumab DME non-responding patients (SWIRL study). [PDF]

BMJ Open Ophthalmol
Lim LW, Choy D, Song WJ, Ngo WK, Thng ZX, Mi HF, Soh YQ, Lilian K, Chin JYH, Chia KJW, Laude A, Tan CS, Lim TH, Too I, Gan NY, Rajagopalan R.   +15 more
europepmc   +1 more source

Treat-and-Extend versus Monthly Regimen in Neovascular Age-Related Macular Degeneration: Results with Ranibizumab from the TREND Study.

Ophthalmology (Rochester, Minn.), 2018
Rufino Silva, A. Berta, M. Larsen, W. Macfadden, C. Feller, J. Monés   +5 more
semanticscholar   +1 more source

Effect of Ranibizumab in Patients with Treatment-Naïve Retinopathy of Prematurity. [PDF]

Turk J Ophthalmol
Khalid H, Malik TG, Amjad A, Khalid I, Muhammad S.   +4 more
europepmc   +1 more source

Resolution of subretinal fluid associated with a spontaneous retinal pigment epithelial tear after intravitreal ranibizumab injection

, 2009
Jeffrey Gale, Joseph Cheung
openalex   +1 more source

Different ranibizumab dosages for retinopathy of prematurity: 5-year follow-up data of the randomised, controlled CARE-ROP Study. [PDF]

BMJ Open Ophthalmol
Stahl A, Bründer MC, Lagrèze WA, Molnár FE, Barth T, Eter N, Guthoff R, Krohne TU, Göpel W, Pfeil JM, CARE-ROP Study Group.   +10 more
europepmc   +1 more source